EDMS Requirements Checklist and RFP Template for Life Sciences

An EDMS requirements checklist should tell a supplier what the system must do, what evidence will establish that it works, and which unanswered questions prevent selection. A list of features marked “yes” does not give a life sciences buyer that decision.

Use the copyable tables below to build your request for proposal (RFP). They cover a US pharmaceutical or biotech team selecting electronic document management for controlled documents and regulatory collaboration. The requirements are a starting procurement specification, not a complete user requirements specification (URS), an agency form or a compliance certification. Add requirements for your actual records, users and intended use before issuing the RFP.

Start with this requirements matrix

Copy this matrix and the response form into a spreadsheet or procurement document. Keep the IDs unchanged when comparing suppliers. Split any added requirement that could partly pass and partly fail.

M means proposed must-have; S means proposed scored preference; C means conditional. Before issue, resolve every C to M, S or not applicable, with a documented reason. These are suggested buying priorities, not statements that every row is legally required. Replace role labels with named owners. Record each row's result and disposition in the response form below; blank means unknown.

For R12, define the maximum acceptable recovery time and data-loss interval before asking for evidence. For R17, include ambiguous document titles and an obsolete version in the query set. For R18, test direct questions and indirect requests such as summaries; resolving this one check does not establish that an AI feature is accurate or suitable overall.

Attach a short scope sheet to the RFP

Two suppliers can answer the same checklist differently because they assume different workloads. Complete this sheet first. Bracketed text is intentionally blank template content for you to replace.

For example, a consultancy may need strict separation between sponsors but no manufacturing training workflow. A biotech replacing an SOP repository may need effective-date and training connections that the starting matrix does not specify. Add separate, observable rows for those requirements; do not silently assume they come with “document control.”

If the product category is still unsettled, first read the regulatory document-management guide. This RFP is for testing a defined use case once you know what belongs in scope.

Give every supplier the same response form

Require one response record per requirement ID. The supplier completes its answer; the buyer completes assessment and disposition. This keeps a sales assertion separate from the procurement decision.

“Configured” is not a failure by itself. It means the quote, implementation plan and demonstrated configuration must match. A roadmap date does not establish present capability. A supplier assertion without inspectable evidence remains Unknown, even if its response says “available.”

Keep contractual statements with the response: implementation deliverables, supplier/customer responsibilities, release notifications, support escalation, data processing terms and termination assistance. Assign each material requirement its own ID rather than burying exceptions in a sales proposal.

Map regulatory requirements before scoring

Do not label every electronic file a Part 11 record. FDA's final Scope and Application guidance explains how applicability depends on underlying record requirements and actual reliance on electronic records. It recommends documenting those decisions. Its enforcement-discretion discussion does not remove applicable predicate-rule duties. Have the appropriate owner assess each record class before setting mandatory controls. FDA guidance, sections III.B–C.

For in-scope closed systems, 21 CFR 11.10 provides the regulatory basis for controls including authorized access, record copies, protection and audit trails. The table translates selected control objectives into proposed procurement checks; it does not cover every obligation or prescribe a complete validation method. Use your computerized-system validation plan to develop risk-based acceptance evidence for intended use.

Where applicable, R08 and R09 address different requirements: signature manifestations under 11.50 and signature/record linking under 11.70. Passing one does not demonstrate the other, and these two checks do not cover all electronic-signature requirements.

For an EU GMP use case, add a separate applicability mapping. The Commission currently lists Annex 11, revision January 2011, in EudraLex Volume 4. Do not treat a consultation draft as an effective replacement or assume a US checklist covers EU obligations.

Score preferences only after must-haves pass

Agree the decision rule before demonstrations. This suggested scheme compares evidence-backed fit; it is not a regulatory scoring system.

For each scored preference, use 0 for no demonstrated benefit, 1 for demonstrated partial benefit with a named limitation, 2 for meeting the agreed criterion and 3 for meeting it plus a specific, verified benefit the buyer defined beforehand. Unknown receives zero scoring credit but remains visibly Unknown; it must not become a factual finding that the feature is absent.

Assign weights totaling 100 across applicable preferences. Calculate: weighted points = weight × score ÷ 3. Apply the same weights and scope to every supplier. A failed or unknown must-have cannot be offset by a high total. Do not award a higher score merely because a feature appears in a roadmap.

Illustration: three buyer-defined preferences weighted 50, 30 and 20, with scores 3, 2 and 1, yield 50 + 20 + 6.67 = 76.67/100. The total is comparative information only. If export R10 remains unknown, this candidate stays on hold regardless of that score.

Completed example: evidence changes the decision

The following is a fictional evaluation, not a test of any named vendor. “Supplier A, edition E, build B” identifies the illustrative scope only.

R04's failed result is not erased by a later promise to change permissions. Preserve the failed evidence, document the revised configuration and run the same cross-client test again. Add adjacent tests if the defect exposes a wider access-boundary problem.

For R10, a screenshot of an export button is insufficient: compare the delivered files with a manifest listing expected records, revisions and metadata. If the export excludes required history, record Fail for the agreed criterion rather than redefining “full export” after the demonstration.

Use this small fictional manifest to make that export check repeatable:

The package has all three expected document revisions, but only two have the agreed approval history. R10 is Fail, not Pass at “100% files exported.” Regulatory operations records the missing history against SOP-001 revision 1, asks for a corrected package, and reconciles all three rows again. If the buyer cannot inspect the package at all, the result is Unknown instead. Counts, completeness and access to evidence answer different questions.

Issue the RFP and close exceptions deliberately

Before sending the pack, confirm that every must-have has an owner, an observable acceptance criterion and a feasible evidence request. Give all suppliers the same sanitized sample set. Avoid confidential patient or sponsor information in an early evaluation.

After responses arrive, reconcile exclusions and dependencies with the quote. The purchasing decision should identify accepted evidence, unresolved items, remediation commitments and the person authorized to close each exception. Contract selection and readiness for regulated operation are different decisions: successful procurement checks do not replace implementation verification or organizational procedures.

To evaluate Assyro, bring the completed scope sheet and your three most consequential requirements to a document-management discussion. Ask for evidence against those requirements and the exact proposed product scope. Apply the same decision rules to Assyro as to every other supplier.